BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32635473)

  • 1. Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells.
    Cash TP; Alcalá S; Rico-Ferreira MDR; Hernández-Encinas E; García J; Albarrán MI; Valle S; Muñoz J; Martínez-González S; Blanco-Aparicio C; Pastor J; Serrano M; Sainz B
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures.
    Alcalá S; Martinelli P; Hermann PC; Heeschen C; Sainz B
    Stem Cells Int; 2019; 2019():1378639. PubMed ID: 31191663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.
    Valle S; Martin-Hijano L; Alcalá S; Alonso-Nocelo M; Sainz B
    Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29373514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting autophagy in pancreatic cancer: The cancer stem cell perspective.
    Troumpoukis D; Papadimitropoulou A; Charalampous C; Kogionou P; Palamaris K; Sarantis P; Serafimidis I
    Front Oncol; 2022; 12():1049436. PubMed ID: 36505808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting
    Alcalá S; Mayoral-Varo V; Ruiz-Cañas L; López-Gil JC; Heeschen C; Martín-Pérez J; Sainz B
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
    PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer?
    Sereti E; Karagianellou T; Kotsoni I; Magouliotis D; Kamposioras K; Ulukaya E; Sakellaridis N; Zacharoulis D; Dimas K
    J Proteomics; 2018 Sep; 188():107-118. PubMed ID: 29398619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer stem cells: A state or an entity?
    Hermann PC; Sainz B
    Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
    Beglyarova N; Banina E; Zhou Y; Mukhamadeeva R; Andrianov G; Bobrov E; Lysenko E; Skobeleva N; Gabitova L; Restifo D; Pressman M; Serebriiskii IG; Hoffman JP; Paz K; Behrens D; Khazak V; Jablonski SA; Golemis EA; Weiner LM; Astsaturov I
    Clin Cancer Res; 2016 Dec; 22(24):6153-6163. PubMed ID: 27384421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and application of patient-derived xenograft models in pancreatic cancer research.
    Wang CF; Shi XJ
    Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.
    Perales-Patón J; Piñeiro-Yañez E; Tejero H; López-Casas PP; Hidalgo M; Gómez-López G; Al-Shahrour F
    Public Health Genomics; 2017; 20(2):81-91. PubMed ID: 28858862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
    Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
    Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
    Adamska A; Domenichini A; Capone E; Damiani V; Akkaya BG; Linton KJ; Di Sebastiano P; Chen X; Keeton AB; Ramirez-Alcantara V; Maxuitenko Y; Piazza GA; De Laurenzi V; Sala G; Falasca M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):312. PubMed ID: 31378204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.
    Allaway RJ; Fischer DA; de Abreu FB; Gardner TB; Gordon SR; Barth RJ; Colacchio TA; Wood M; Kacsoh BZ; Bouley SJ; Cui J; Hamilton J; Choi JA; Lange JT; Peterson JD; Padmanabhan V; Tomlinson CR; Tsongalis GJ; Suriawinata AA; Greene CS; Sanchez Y; Smith KD
    Oncotarget; 2016 Mar; 7(13):17087-102. PubMed ID: 26934555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.